Quality by Design (QbD) & Paperless Lab Consultancy
Making Informatics Work Across Your Teams
Gonzalo Hernandez
FAES 2020: Efficiency in R&D+i

Name Gonzalo Hernandez Herrero  
Company
Web faesfarma.com
Job Title R&D+i Director
EMail
ghernandez@faes.es
Presentation On request

Abstract

At the end of 2014, FAES FARMA R&D+i Department defined a strategic plan called FAES 2020. This plan is based on the development of 20 new drugs which registration dossiers should be submitted before the end of 2020 and 50% of them should by then be protected by a patent file.

In order to achieve the goals of FAES 2020 R&D+i team has launched three strategic initiatives:

  1. The construction of new infrastructures engaged in R&D, such as a new pilot plant and the expansion of the laboratory of analytics.
  2. The development of our new pool of professionals dedicated to R&D+i.
  3. The launch of GIDARIA project as the simplification of our processes involved in R&D, the development of new SOPs and the acquisition of new systems that support efficiency in our R&D+i.
 


Biography Gonzalo Hernández, Bachelor of Medicine and Surgery, Master in Marketing, with over 25 years' solid experience in the Pharmaceutical Industry, has been working within several Spanish and international pharmaceutical companies in different positions, from medical advisor to managing responsibilities.
Gonzalo was appointed as R&D and innovation Director at FAES FARMA, S.A. in September 2014. He currently coordinates and directs the areas of API and Pharma Development, Clinical Research with the support of multi-functional initiative teams with the challenge of generating new products and technological platforms for the company.
Gonzalo Hernández has extensive experience in all stages of pharmaceutical development – from target identification, through the complete cycle of clinical development, to submission and approval processes with Regulatory Authorities around the world. Moreover, he is the co-author of numerous papers and patents.